Limited prognostic value of the International Prognostic Score in advanced stage human immunodeficiency virus infection-related Hodgkin lymphoma treated with the doxorubicin, bleomycin, vinblastine, and dacarbazine regimen

Leuk Lymphoma. 2009 Oct;50(10):1718-20. doi: 10.1080/10428190903174359.
No abstract available

Publication types

  • Evaluation Study
  • Letter
  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Anti-HIV Agents / therapeutic use
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Antiretroviral Therapy, Highly Active
  • Bleomycin / administration & dosage
  • Combined Modality Therapy
  • Dacarbazine / administration & dosage
  • Doxorubicin / administration & dosage
  • Female
  • HIV Infections / drug therapy
  • Hodgkin Disease / drug therapy
  • Hodgkin Disease / mortality*
  • Hodgkin Disease / radiotherapy
  • Humans
  • Lymphoma, AIDS-Related / drug therapy
  • Lymphoma, AIDS-Related / mortality*
  • Lymphoma, AIDS-Related / radiotherapy
  • Male
  • Middle Aged
  • Prognosis
  • Radiotherapy, Adjuvant
  • Retrospective Studies
  • Severity of Illness Index*
  • Survival Analysis
  • Treatment Outcome
  • Vinblastine / administration & dosage
  • Young Adult

Substances

  • Anti-HIV Agents
  • Bleomycin
  • Vinblastine
  • Dacarbazine
  • Doxorubicin

Supplementary concepts

  • ABVD protocol